FOLD

8.02

2.17% 0.17

Dopo l'orario di chiusura: 8.02

Amicus Therapeutics Inc (FOLD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché FOLD Giù? Forum Previsione

Precedente Chiudi:

$7.85

Aprire:

$7.83

Volume 24 ore:

5.53M

Relative Volume:

1.22

Capitalizzazione di mercato:

$2.47B

Reddito:

$493.67M

Utile/perdita netta:

$-104.69M

Rapporto P/E:

-23.59

EPS:

-0.34

Flusso di cassa netto:

$-31.51M

1 W Prestazione:

+4.84%

1M Prestazione:

+17.42%

6M Prestazione:

-11.96%

1 anno Prestazione:

-30.38%

Intervallo 1D:

$7.81

$8.03

Intervallo di 1 settimana:

$7.56

$8.03

Portata 52W:

$5.51

$12.65

Amicus Therapeutics Inc Stock (FOLD) Company Profile

Nome

Amicus Therapeutics Inc

Settore

Healthcare (1151)

Industria

Biotechnology (650)

Telefono

(609) 662-2000

Indirizzo

47 HULFISH STREET, PRINCETON, NJ

Dipendente

499

Cinguettio

@amicusrx1

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

FOLD's Discussions on Twitter

Confronta FOLD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FOLD Amicus Therapeutics Inc	8.02	2.43B	493.67M	-104.69M	-31.51M	-0.34
VRTX Vertex Pharmaceuticals Inc	396.93	102.81B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	453.54	58.59B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	567.22	61.25B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	733.66	43.23B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	318.73	36.53B	3.81B	-644.79M	-669.77M	-6.24

Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-12-13	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-09-06	Iniziato	Jefferies	Buy
2024-05-30	Iniziato	Wells Fargo	Overweight
2024-05-14	Aggiornamento	Guggenheim	Neutral → Buy
2023-12-19	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-09-09	Iniziato	Morgan Stanley	Equal-Weight
2022-04-13	Ripresa	Goldman	Neutral
2022-01-14	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-11-15	Aggiornamento	Stifel	Hold → Buy
2021-09-30	Aggiornamento	JP Morgan	Neutral → Overweight
2021-07-19	Ripresa	BTIG Research	Buy
2021-05-27	Iniziato	Needham	Hold
2021-05-21	Iniziato	UBS	Buy
2021-04-14	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2021-03-02	Iniziato	Stifel	Hold
2021-02-12	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2021-02-12	Downgrade	JP Morgan	Overweight → Neutral
2020-12-28	Ripresa	Cantor Fitzgerald	Overweight
2020-12-10	Downgrade	Citigroup	Buy → Neutral
2020-11-11	Iniziato	Berenberg	Hold
2020-06-17	Iniziato	BTIG Research	Buy
2020-02-04	Ripresa	Cantor Fitzgerald	Overweight
2019-11-12	Reiterato	H.C. Wainwright	Buy
2019-06-17	Iniziato	H.C. Wainwright	Buy
2019-06-05	Reiterato	Cantor Fitzgerald	Overweight
2019-04-05	Iniziato	Janney	Buy
2019-01-30	Iniziato	Cantor Fitzgerald	Overweight
2018-10-29	Iniziato	Citigroup	Neutral
2018-08-17	Downgrade	Chardan Capital Markets	Buy → Neutral
2017-10-06	Ripresa	Goldman	Neutral
2017-09-13	Reiterato	Chardan Capital Markets	Buy
2017-08-10	Reiterato	Chardan Capital Markets	Buy
2017-01-24	Aggiornamento	Robert W. Baird	Neutral → Outperform
2016-05-18	Iniziato	BofA/Merrill	Buy
2016-04-14	Iniziato	Robert W. Baird	Neutral
2016-04-12	Reiterato	Chardan Capital Markets	Buy
2015-09-16	Downgrade	Chardan Capital Markets	Buy → Neutral
2015-06-16	Reiterato	Chardan Capital Markets	Buy

Mostra tutto

Amicus Therapeutics Inc Borsa (FOLD) Ultime notizie

Sep 03, 2025

Russell Investments Group Ltd. Purchases 89,287 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat

Sep 03, 2025

Wall Street Zen Downgrades Amicus Therapeutics (NASDAQ:FOLD) to Hold - MarketBeat

Sep 03, 2025

Real time social sentiment graph for Amicus Therapeutics Inc.2025 Macro Impact & Safe Entry Momentum Stock Tips - Newser

Sep 03, 2025

PDT Partners LLC Grows Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Sep 03, 2025

Is Amicus Therapeutics Inc. reversing from oversold territory2025 Top Decliners & Weekly Top Gainers Alerts - Newser

Sep 03, 2025

Ranking Amicus Therapeutics Inc. among high performing stocks via toolsCEO Change & Long-Term Capital Growth Strategies - Newser

Sep 03, 2025

Reversal indicators forming on Amicus Therapeutics Inc. stockJuly 2025 Drop Watch & Reliable Price Breakout Alerts - Newser

Sep 03, 2025

Using Python tools to backtest Amicus Therapeutics Inc. strategiesCEO Change & Reliable Price Action Trade Plans - Newser

Sep 03, 2025

Earnings visualization tools for Amicus Therapeutics Inc.2025 AllTime Highs & Verified Short-Term Plans - Newser

Sep 03, 2025

How to build a custom watchlist for Amicus Therapeutics Inc.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser

Sep 03, 2025

Applying Wyckoff theory to Amicus Therapeutics Inc. stockJuly 2025 Levels & Safe Capital Investment Plans - Newser

Sep 03, 2025

Is Amicus Therapeutics Inc. stock a buy or sell getLinesFromResByArray error: size == 0 - mustnews.co.kr

Sep 03, 2025

Sep 02, 2025

Has Amicus Therapeutics Inc. found a price floorMarket Risk Analysis & Low Risk High Reward Trade Ideas - Newser

Sep 02, 2025

What makes Amicus Therapeutics Inc. stock price move sharplyJuly 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser

Sep 02, 2025

Amicus Therapeutics Inc. stock momentum explainedM&A Rumor & Safe Entry Point Identification - Newser

Sep 02, 2025

Evaluating Amicus Therapeutics Inc. with trendline analysisWeekly Trade Analysis & Fast Gaining Stock Reports - Newser

Sep 02, 2025

Analyzing Amicus Therapeutics Inc. with risk reward ratio chartsWeekly Market Outlook & Target Return Focused Stock Picks - Newser

Sep 02, 2025

Price Channel Expanding on Amicus Therapeutics Inc.’s Chart getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 02, 2025

Exit strategy if you’re trapped in Amicus Therapeutics Inc.July 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - Newser

Sep 02, 2025